Ovarian reserve testing and the use of prognostic models in patients with subfertility.
about
Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertilityIntra-uterine insemination versus fallopian tube sperm perfusion for non-tubal infertilityIntrauterine insemination versus fallopian tube sperm perfusion for non tubal infertilityAnti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve MarkersAge-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women.Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSIUtility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis.Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.Should endometriomas be treated before IVF-ICSI cycles?Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation.Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF.Ovarian aging and menopause: current theories, hypotheses, and research models.The anti mullerian hormone- a novel marker for assessing the ovarian reserve in women with regular menstrual cyclesAntral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin's disease.Management of female infertility from hormonal causes.Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-rEfficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age.Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.Anti-mullerian hormone as a marker of ovarian reserve.Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.Intercycle variabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging: a prospective study.Prospective evaluation of early follicular ovarian stromal blood flow in infertile women undergoing IVF-ET treatment.Obesity and Clomiphene Challenge Test as predictors of outcome of in vitro fertilization and intracytoplasmic sperm injection.The role of N-Acetylcysteine in preventing cyclophosphamide-induced gonadotoxicity: An experimental study in rats.Ultrasonography in In Vitro Fertilization
P2860
Q24202856-F4D0546F-62D6-4FA9-BA1C-B02F9522F2EEQ24240997-728B4A0B-E90D-4AE2-BE3A-EA69DAF4E655Q24246670-C7B1395C-760D-4C59-985F-6C9CEC0025FCQ26765770-5E757A32-0BED-488F-A04E-1DC789AD424FQ35538995-349270F4-D796-4357-85C1-EF4565E1D6DEQ35763800-0DB1023E-43D1-4257-9D0A-D4920FBC0DFDQ35856600-AA4BF5C8-2269-4E22-AA58-003918DE79F1Q35966481-E07C0B78-77E2-4F7E-A045-E09E98E3348DQ36254681-2D6F508B-764B-4618-9FD2-FC4649A6CD1EQ36269371-672348A1-7524-4076-8438-4CB877C099CFQ36270456-C0F1D570-B2E5-4573-AB47-CD8134F0DFA9Q36270584-EC243CFA-7D5A-4C91-80F5-6973F89BB08BQ36337138-44488014-BE47-4B90-B5C8-44DA4FEAC9DCQ36554078-51C2FB2F-62CE-4226-8BA5-E371A4B6F6E2Q36875001-84854BC8-39D5-4958-8EDD-B492A2FAE9DEQ36995795-CADDADF0-43E9-4D3F-9419-7432D212BD48Q38153916-BB835E8E-39BA-4692-8FE1-E1AABD8304D5Q42435624-FB2EB948-9D07-45AA-A2DE-9C70E898EF53Q42497049-3F823C1B-2635-4E26-A989-D5D2CEA8F67FQ45234419-97383642-779E-4352-982C-FBD58EA00BA3Q45282186-5BC33185-DE66-432F-8178-9BC6D79159F9Q46144166-48F352DE-173D-40A2-BC65-ADD2CCC522BEQ46600423-132663D7-9554-41F1-8D25-61B696B3FAC9Q48652277-371CD31D-FBAF-437A-B450-36FE0CEB0710Q50664963-E5E4B5B5-984B-49D3-BFB4-4922ED894EE6Q50971754-AF5F4FD8-ECD3-4C9F-91B4-3B1584AD2246Q57772074-6972C501-101D-49F6-A073-690D31E668F2
P2860
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@ast
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@en
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@nl
type
label
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@ast
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@en
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@nl
prefLabel
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@ast
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@en
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@nl
P356
P1476
Ovarian reserve testing and the use of prognostic models in patients with subfertility.
@en
P2093
P304
P356
10.1093/HUMUPD/7.6.581
P577
2001-11-01T00:00:00Z